Search
Finance

Novo Nordisk Shares Plunge After Obesity Drug Fails to Beat Zepbound

By: 1newsmedia.com

Date:




The CagriSema study results are a setback for the Danish drugmaker in its efforts to regain ground lost to Eli Lilly in the obesity-drug market.



Source link

Previous article
Kara Braxton, two-time WNBA champion, dies at 43
Next article
Brandi Carlile Confirms New Highwomen Album Is Coming
1newsmedia.com
1newsmedia.comhttps://1newsmedia.com

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Veteran charged in series of Atlanta-area shootings dies in jail

1newsmedia.com 1newsmedia.com -
Navy veteran charged in series of Atlanta-area shootings dies...

AkzoNobel Posts Higher Adjusted Earnings Amid Difficult Context

1newsmedia.com 1newsmedia.com -
The company’s adjusted earnings before interest, taxes, depreciation and...

NBA winners and losers: Lakers organization shines on every level vs. Rockets

1newsmedia.com 1newsmedia.com -

U.S. forces ready to restart fighting if necessary, officials say

1newsmedia.com 1newsmedia.com -

About us

1 News Media is your trusted source for local news, stories, and events that matter most to our community. Based in the heart of the region, we are committed to delivering timely, accurate, and meaningful coverage—from breaking news and local government updates to community features, sports, and culture.

The latest

Veteran charged in series of Atlanta-area shootings dies in jail

Local News 0
Navy veteran charged in series of Atlanta-area shootings dies...

AkzoNobel Posts Higher Adjusted Earnings Amid Difficult Context

Finance 0
The company’s adjusted earnings before interest, taxes, depreciation and...

NBA winners and losers: Lakers organization shines on every level vs. Rockets

Sports 0

© 2026-2027 All Rights Reserved. 1 News Media